Zus Health Closes $40 Million In Funding

By Annie Baker • Mar 20, 2023
  • Zus Health announced it raised $40 million in funding. These are the details.

Zus Health – a next-generation shared health data platform bringing distributed patient data directly to the point of care – announced that the company has closed a $40 million financing. The investors include JAZZ Venture Partners, F-Prime Capital, Maverick Ventures, and Andreessen Horowitz (a16z).

Zus plans to use this funding to continue growing its platform with additional unique data sources, workflow and referral solutions, and integration pathways to empower healthcare providers to leverage external patient data in their care and collaborate around a shared patient record.

Plus Elation Health, a rapidly growing technology platform for high-value primary care currently supporting millions of patients, is enhancing its own data collaboration systems by integrating the Zus Aggregated Profile. The clinicians will be able to access expanded patient records from hospitals, clinics, labs, and pharmacies in real time which help ensure the highest-quality care.

Healthcare data today remains highly fragmented with providers frequently spending more time gathering patient data and entering it into their EMR than with their patients delivering care. And the industry desperately lacks information fluidity and with that a shared, consistent understanding across providers of how and when their patients are interacting with the healthcare system.

Plus Zus is building a healthcare common ground. In order for healthcare technology to deliver on the promise of transforming care delivery, patient data must be rapidly, accurately, and securely moved through the healthcare system to the right place at the right time. With a connected data platform, Zus is uniquely positioned to address these needs and enable the long-awaited collaborative healthcare ecosystem.

The Zus platform is centered around the Zus Aggregated Profile (ZAP), which represents a single, comprehensive, and actionable view of a patient’s healthcare information. And alongside the ZAP, the Zus platform includes an FHIR-native data store and is built on common patient record technology to facilitate real-time, cross-provider insights into every patient, which saves customers a significant amount of time in their daily operations.

The companies succeeding in healthcare today are those that have proven they can truly scale, and the ZAP enables provider scalability by empowering customers to serve a higher volume of patients without compromising on care quality or drastically increasing personnel.

Along with providing physician, clinical staff, and developer time-savings, patient data access can also lead to improved health outcomes, higher patient satisfaction, and greater cost savings for healthcare organizations by facilitating more informed, holistic care and fewer duplicated tests and procedures. And Zus plans to scale its platform to become the go-to source of aggregated health records for Americans, replacing pages of unstructured data from PDFs and faxes with an always-on network of healthcare insights.


“The Zus partnership will drastically accelerate Elation’s ability to build out market-leading EHR solutions to support population health and value-based care initiatives. Together, Elation and Zus are optimizing how external health data is synthesized within the EHR platform, which will support many of our key goals, such as reducing clinician burden, strengthening the patient-physician relationship, and driving primary care success.”

— Kyna Fong, CEO and co-founder of Elation Health

“We have found a critically important role for Zus as the common information ground behind the many great electronic medical records, CRMs, and patient care technologies that healthcare works with. What has been long overdue is a vision of digestible, comprehensive patient information at the point of care, which Zus is uniquely situated to bring about.”

— Zus CEO Jonathan Bush

“Zus’s ability in this market to secure the capital and support they need to really scale their platform is a testament to the potential of the company to create the connective tissue for healthcare. Healthcare has needed a shared patient record for decades at this point, and we believe Zus is our best hope to achieve this vision and help deliver on the promise of technology-enabled care.”

— Andrew Firlik, Managing Partner at JAZZ Venture Partners and newly added Zus board member